Literature DB >> 26582872

Outbreak of KPC-3 Producing Carbapenem-Resistant Klebsiella pneumoniae in a US Pediatric Hospital.

Terri Stillwell1, Michael Green2, Karen Barbadora2, Juliet G Ferrelli3, Terri L Roberts4, Scott J Weissman5, Andrew Nowalk2.   

Abstract

BACKGROUND: The increase in carbapenem-resistant Enterobacteriaceae (CRE) infections is a critical public health issue. We recently experienced the largest single-center pediatric outbreak of carbapenem-resistant Klebsiella pneumoniae (CRKP) at our hospital. The objective of this study was to describe the molecular epidemiology of this outbreak before and after infection-prevention interventions.
METHODS: All positive cultures and associated clinical conditions were reviewed to determine whether health care-associated infections (HAIs) exist. HAIs were defined using Centers for Disease Control and Prevention guidelines. CRKP isolates were collected and screened for the presence of β-lactamase genes. Strain relatedness of CRKP isolates was determined by field-inversion gel electrophoresis (FIGE) and multilocus sequence typing (MLST). Polymerase chain reaction (PCR) amplification and sequencing of blaTEM, blaSHV, and blaKPC genes were performed on representative isolates.
RESULTS: During March-July 2010, 18 CRKP isolates were recovered from 15 unique patients. Six isolates were considered HAIs; all were central-line-associated bloodstream infections. All isolates testing positive by PCR for blaKPC were found to carry KPC-3 in transposon Tn4401 isotype "b." FIGE revealed 2 prevalent patterns (accounting for 10 and 3 CRKP isolates, respectively) that MLST demonstrated to consist entirely of strains from ST730; the remaining FIGE types corresponded to ST14, ST15, and ST1559 (a single-locus variant of ST730), with these alternate backgrounds appearing later in the outbreak. New CRKP cases decreased after the implementation of infection-control interventions. All isolates were ciprofloxacin sensitive.
CONCLUSIONS: Molecular analyses document the introduction of a KPC-3-producing CRKP clone into our hospital setting, though some isolates appear to have other mechanisms of carbapenem resistance. The transition to a polyclonal epidemiology suggests that the initial outbreak was due to nosocomial spread of a single ST730 clone, while latter isolates may have been secondary to the introduction of a blaKPC-3/Tn4401 isotype "b"-containing plasmid into other K pneumoniae strain backgrounds versus new carbapenemase-producing bacteria.
© The Author 2014. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Klebsiella pneumoniae; carbapenemase; infection control; nosocomial infection; pediatric

Mesh:

Substances:

Year:  2014        PMID: 26582872     DOI: 10.1093/jpids/piu080

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  12 in total

Review 1.  The Growing Threat of Antibiotic Resistance in Children.

Authors:  Rachel L Medernach; Latania K Logan
Journal:  Infect Dis Clin North Am       Date:  2018-03       Impact factor: 5.982

Review 2.  The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.

Authors:  Latania K Logan; Robert A Weinstein
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

3.  Analysis of β-Lactamase Resistance Determinants in Enterobacteriaceae from Chicago Children: a Multicenter Survey.

Authors:  Latania K Logan; Andrea M Hujer; Steven H Marshall; T Nicholas Domitrovic; Susan D Rudin; Xiaotian Zheng; Nadia K Qureshi; Mary K Hayden; Felicia A Scaggs; Anand Karadkhele; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

4.  A Multi-Centered Case-Case-Control Study of Factors Associated With Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Infections in Children and Young Adults.

Authors:  Latania K Logan; David C Nguyen; Felicia A Scaggs Huang; Nadia K Qureshi; Angella Charnot-Katsikas; Allison H Bartlett; Xiaotian Zheng; Andrea M Hujer; T Nicholas Domitrovic; Steven H Marshall; Robert A Bonomo; Robert A Weinstein
Journal:  Pediatr Infect Dis J       Date:  2019-05       Impact factor: 2.129

5.  Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.

Authors:  Latania K Logan; John P Renschler; Sumanth Gandra; Robert A Weinstein; Ramanan Laxminarayan
Journal:  Emerg Infect Dis       Date:  2015-11       Impact factor: 6.883

6.  Molecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary - care hospitals in Medellín, Colombia: an increasing problem.

Authors:  Johanna M Vanegas; O Lorena Parra; J Natalia Jiménez
Journal:  BMC Infect Dis       Date:  2016-09-01       Impact factor: 3.090

7.  Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infections in Eastern China.

Authors:  Bing Zheng; Yingxin Dai; Yang Liu; Weiyang Shi; Erkuan Dai; Yichao Han; Dandan Zheng; Yuetian Yu; Min Li
Journal:  Front Microbiol       Date:  2017-06-13       Impact factor: 5.640

8.  Insights on Klebsiella pneumoniae Biofilms Assembled on Different Surfaces Using Phenotypic and Genotypic Approaches.

Authors:  Maria Bandeira; Vítor Borges; João P Gomes; Aida Duarte; Luisa Jordao
Journal:  Microorganisms       Date:  2017-04-03

9.  Identity of blaCTX-M Carrying Plasmids in Sequential ESBL-E. coli Isolates from Patients with Recurrent Urinary Tract Infections.

Authors:  Nahid Karami; Sriram Kk; Shora Yazdanshenas; Yii-Lih Lin; Daniel Jaén-Luchoro; Elina Ekedahl; Sanjana Parameshwaran; Anna Lindblom; Christina Åhrén; Fredrik Westerlund
Journal:  Microorganisms       Date:  2021-05-25

10.  Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients.

Authors:  John S Bradley; Jon Armstrong; Antonio Arrieta; Raafat Bishai; Shampa Das; Shirley Delair; Timi Edeki; William C Holmes; Jianguo Li; Kathryn S Moffett; Deepa Mukundan; Norma Perez; José R Romero; David Speicher; Janice E Sullivan; Diansong Zhou
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.